Skip to main content
Fig. 4 | Journal of Nanobiotechnology

Fig. 4

From: Exosome-mediated targeted delivery of miR-210 for angiogenic therapy after cerebral ischemia in mice

Fig. 4

RGD-exo:miR-210 targets integrin β3 in the lesion region after intravenous administration. a–d Co-labeled fluorescence images of PBS, Exo:miR-210, Scr-exo:miR-210 or RGD-exo:miR-210 (red) with integrin β3 (green) in the ischemic cortex 6 h after intravenous administration of tdTomato-labeled exosomes. Blue indicates nuclei. The triangles indicate the co-localization of RGD-exo and integrin β3. Scale bar: 50 µm

Back to article page